Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
R Thomas LumbersNicole MartinKarthick ManoharanJames ThomasL Ceri DaviesPublished in: Heart (British Cardiac Society) (2019)